Skip to main content Accessibility help

The Sir David Cuthbertson Medal Lecture Hunting for new pieces to the complex puzzle of obesity: The Annual Meeting of the Nutrition Society and the British Association for Parenteral and Enteral Nutrition was held at The International Centre, Telford on 16–17 November 2005

  • Gema Frühbeck (a1)


Disentangling the neuroendocrine systems that regulate energy homeostasis and adiposity has been a long-standing challenge in pathophysiology, with obesity being an increasingly important public health problem. Adipose tissue is no longer considered a passive bystander in body-weight regulation. It actively secretes a large number of hormones, growth factors, enzymes, cytokines, complement factors and matrix proteins, at the same time as expressing receptors for most of these elements, which influence fuel storage, mobilisation and utilisation at both central and peripheral sites. Thus, an extensive cross talk at a local and systemic level in response to specific external stimuli or metabolic changes underpins the multifunctional characteristics of adipose tissue. In addition to the already-known adipokines, such as IL, TNFα, leptin, resistin and adiponectin, more recently attention has been devoted to ‘newcomers’ to the ‘adipose tissue arena’, which include aquaporin, caveolin, visfatin, serum amyloid A and vascular endothelial growth factor. While in vitro and in vivo experiments have provided extremely valuable information, the advances in genomics, proteomics and metabolomics are offering a level of information not previously attainable to help unlock the molecular basis of obesity. The potential and power of combining pathophysiological observations with the wealth of information provided by the human genome, knock-out models, transgenesis, DNA microarrays, RNA silencing and other emerging technologies offer a new and unprecedented view of a complex disease, conferring novel insights into old questions by identifying new pieces to the unfinished jigsaw puzzle of obesity.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The Sir David Cuthbertson Medal Lecture Hunting for new pieces to the complex puzzle of obesity
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The Sir David Cuthbertson Medal Lecture Hunting for new pieces to the complex puzzle of obesity
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The Sir David Cuthbertson Medal Lecture Hunting for new pieces to the complex puzzle of obesity
      Available formats


Corresponding author

Corresponding author: Dr Gema Frühbeck, fax +34 948 29 65 00, email


Hide All
Aitman, TJ (2003) Genetic medicine and obesity. New England Journal of Medicine 348, 21382139.
Allison, SP (2005) Integrated nutrition. Proceedings of the Nutrition Society 64, 319323.
Ariyasu, H, Takaya, K, Tagami, T, Ogawa, Y, Hosoda, K, Akamizu, Tet al. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. Journal of Clinical Endocrinology and Metabolism 86, 47534758.
Arner, P (2005a) Insulin resistance in type 2 diabetes – role of the adipokines. Current Molecular Medicine 5, 333339.
Arner, P (2005b) Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Practice and Research in Clinical Endocrinology and Metabolism 19, 471482.
Arner, P (2006) Visfatin – a true or false trail to type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 91, 2830.
Ashrafi, K, Chang, FY, Watts, JL, Fraser, AG, Kamath, RS, Ahringer, J & Ruvkun, G (2003) Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268272.
Badman, MK & Flier, JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307, 19091914.
Bai, Y, Zhang, S, Kim, KS, Lee, JK & Kim, KH (1996) Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. Journal of Biological Chemistry 271, 1393913942.
Baldanzi, G, Filigheddu, N, Cutrupi, S, Catapano, F, Bonissoni, S, Fubini, Aet al. (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. Journal of Cell Biology 159, 10291037.
Bell, CG, Walley, AJ & Froguel, P (2005) The genetics of human obesity. Nature Reviews Genetics 6, 221234.
Beltowski, J (2006a) Role of leptin in blood pressure regulation and arterial hypertension. Journal of Hypertension 24, 789801.
Beltowski, J (2006b) Leptin and atherosclerosis. Atherosclerosis 189, 4760.
Beltowski, J, Wójcicka, G & Borkowska, E (2002) Human leptin stimulates systemic nitric oxide production in the rat. Obesity Research 10, 939946.
Beltowski, J, Wojcicka, G & Jamroz-Wisniewska, A (2006) Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sciences 79, 6371.
Berg, AH & Scherer, PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circulation Research 96, 939949.
Berndt, J, Kloting, N, Kralisch, S, Kovacs, P, Fasshauer, M, Schon, MR, Stumvoll, M & Bluher, M (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54, 29112916.
Blüher, M (2005) Transgenic animal models for the study of adipose tissue biology. Best Practice and Research in Clinical Endocrinology and Metabolism 19, 605623.
Bodart, V, Febbraio, M, Demers, A, McNicoll, N, Pohankova, P, Perreault, A, Sejlitz, T, Escher, E, Silverstein, RL, Lamontagne, D & Ong, H (2002) CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circulation Research 90, 844849.
Borodina, I & Nielsen, J (2005) From genomes to in silico cells via metabolic networks. Current Opinion in Biotechnology 16, 350355.
Bottini, E & Gloria-Bottini, F (1999) Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 48, 949951.
Bray, GA & York, DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiological Reviews 59, 779809.
Buchwald, H, Avidor, Y, Braunwald, E, Jensen, MD, Pories, W, Fahrbach, K & Schoelles, K (2004) Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 292, 17241737.
Calle, EE, Rodriguez, C, Walker-Thurmond, K & Thun, MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 348, 16251638.
Cao, JM, Ong, H & Chen, C (2006) Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends in Endocrinology and Metabolism 17, 1318.
Capozza, F, Combs, TP, Cohen, AW, Cho, YR, Park, SY, Schubert, Wet al. (2005) Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology 288, C1317C1331.
Carella, M, Volinia, S & Gasparini, P (2003) Nanotechnologies and microchips in genetic diseases. Journal of Nephrology 16, 597602.
Chaldakov, GN, Tonchev, AB, Georgieva, Z, Ghenev, PI & Stankulov, IS (2005) Adipobiology of inflammation. Biomedical Reviews 16, 8388.
Chen, M-P, Chung, F-M, Chang, D-M, Tsai, JC-R, Huang, H-F, Shin, S-J & Lee, Y-J (2006) Elevated plasma levels of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 91, 295299.
Clement, K (2005) Genetics of human obesity. Proceedings of the Nutrition Society 64, 133142.
Clément, K, Viguerie, N, Poitou, C, Carette, C, Pelloux, V, Curat, CAet al. (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB Journal 18, 16571669.
Cohen, AW, Combs, TP, Scherer, PE & Lisanti, MP (2003a) Role of caveolin and caveolae in insulin signaling and diabetes. American Journal of Physiology 285, E1151E1160.
Cohen, AW, Hnasko, R, Schubert, W & Lisanti, MP (2004) Role of caveolae and caveolins in health and disease. Physiological Reviews 84, 13411379.
Cohen, AW, Razani, B, Wang, XB, Combs, TP, Williams, TM, Scherer, PE & Lisanti, MP (2003b) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology 285, C222C235.
Cohen, AW, Schubert, W, Brasaemle, DL, Scherer, PE & Lisanti, MP (2005) Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes 54, 679686.
Coleman, DL (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141148.
Collier, G, Walder, K, De Silva, A, Tenne-Brown, J, Sanigorski, A, Segal, D, Kantham, L & Augert, G (2002) New approaches to gene discovery with animal models of obesity and diabetes. Annals of the New York Academy of Sciences 967, 403413.
Copland, JA, Davies, PJ, Shipley, GL, Wood, CG, Luxon, BA & Urban, RJ (2003) The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Progress in Hormone Research 58, 2553.
Correia, ML & Haynes, WG (2004) Leptin, obesity and cardiovascular disease. Current Opinion in Nephrology and Hypertension 13, 215223.
Crookes, PF (2006) Surgical treatment of morbid obesity. Annual Reviews of Medicine 57, 243264.
Cummings, DE & Schwartz, MW (2003) Genetics and pathophysiology of human obesity. Annual Review of Medicine 54, 453471.
Cummings, DE & Shannon, MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? Journal of Clinical Endocrinology and Metabolism 88, 29993002.
Cummings, DE, Weigle, DS, Frayo, RS, Breen, PA, Ma, MK, Dellinger, EP & Purnell, JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 346, 16231630.
Date, Y, Kojima, M, Hosoda, H, Sawaguchi, A, Mondal, MS, Suganuma, T, Matsukura, S, Kangawa, K & Nakazato, M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141, 42554261.
Diéguez, C & Casanueva, FF (2000) Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. European Journal of Endocrinology 142, 413417.
Droit, A, Poirier, GG & Hunter, JM (2005) Experimental and bioinformatic approaches for interrogating protein-protein interactions to determine protein function. Journal of Molecular Endocrinology 34, 263280.
Fantuzzi, G (2005) Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology 115, 911919.
Fantuzzi, G & Faggioni, R (2000) Leptin in the regulation of immunity, inflammation and hematopoiesis. Journal of Leukocyte Biology 68, 437446.
Faraj, M, Havel, PJ, Phélis, S, Blank, D, Sniderman, AD & Cianflone, K (2003) Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism 88, 15941602.
Farooqi, IS & O'Rahilly, S (2005) Monogenic obesity in humans. Annual Review of Medicine 56, 443458.
Flier, JS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337350.
Fontaine, KR, Redden, DT, Wang, C, Westfall, AO & Allison, DB (2003) Years of life lost due to obesity. Journal of the American Medical Association 289, 187193.
Fortuño, A, Rodríguez, A, Gómez-Ambrosi, J, Muñiz, P, Salvador, J, Díez, J & Frühbeck, G (2002) Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 143, 35553560.
Frayn, KN, Karpe, F, Fielding, BA, Macdonald, IA & Coppack, SW (2003) Integrative physiology of human adipose tissue. International Journal of Obesity 27, 875888.
Frisch, RE & McArthur, JW (1974) Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185, 949951.
Frühbeck, G (1999) Pivotal role of nitric oxide in the control of blood pressure following leptin administration. Diabetes 48, 903908.
Frühbeck, G (2001) A heliocentric view of leptin. Proceedings of the Nutrition Society 60, 301318.
Frühbeck, G (2004a) The adipose tissue as a source of vasoactive factors. Current Medicinal Chemistry – Cardiovascular & Hematological Agents 2, 197208.
Frühbeck, G (2004b) Screening and interventions for obesity in adults. Annals of Internal Medicine 141, 245246.
Frühbeck, G (2005a) Overnutrition. In Clinical Nutrition, pp. 3061. [Gibney, MJ, Elia, M, Ljungqvist, O and Dowsett, J editors]. Oxford: Blackwell Publishing.
Frühbeck, G (2005b) Aquaporin enters the picture. Nature 438, 436437.
Frühbeck, G (2005c) Does a NEAT difference in energy expenditure lead to obesity? Lancet 366, 615616.
Frühbeck, G (2006) Intracellular signalling pathways activated by leptin. Biochemical Journal 393, 720.
Frühbeck, G, Aguado, M & Martínez, JA (1997) In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine-paracrine role of leptin. Biochemical and Biophysical Research Communications 240, 590594.
Frühbeck, G, Aguado, M, Gómez-Ambrosi, J & Martínez, JA (1998) Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochemical and Biophysical Research Communications 240, 590594.
Frühbeck, G, Catalán, V, Gómez-Ambrosi, J & Rodríguez, A (2006) Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways. Trends in Pharmacological Sciences 27, 345347.
Frühbeck, G, Diez-Caballero, A, Gil, MJ, Montero, I, Gómez-Ambrosi, J, Salvador, J & Cienfuegos, JA (2004a) The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obesity Surgery 14, 606612.
Frühbeck, G, Diez-Caballero, A & Gil, MJ (2004b) Fundus functionality and ghrelin concentrations after bariatric surgery. New England Journal of Medicine 350, 308309.
Frühbeck, G, Diez-Caballero, A, Gómez-Ambrosi, J, Cienfuegos, JA & Salvador, J (2003) Doctors underestimate obesity. British Medical Journal 326, 102103.
Frühbeck, G, Diez-Caballero, A, Gómez-Ambrosi, J, Gil, MJ, Monreal, I, Salvador, J & Cienfuegos, JA (2002) Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding. Obesity Surgery 12, 366371.
Frühbeck, G & Gómez-Ambrosi, J (2001a) Rationale for the existence of additional adipostatic hormones. FASEB Journal 15, 19962006.
Frühbeck, G & Gómez-Ambrosi, J (2001b) Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cellular Signalling 13, 827833.
Frühbeck, G & Gómez-Ambrosi, J (2003) Control of body weight: a physiologic and transgenic perspective. Diabetologia 46, 143172.
Frühbeck, G & Gómez-Ambrosi, J (2005) Adipose tissue. In Encyclopedia of Human Nutrition, vol. 1, 2nd ed., pp. 114 [Caballero, B, Allen, L and Prentice, Aeditors]. Oxford: Elsevier Ltd.
Frühbeck, G, Gómez-Ambrosi, J, Muruzábal, FJ & Burrell, MA (2001a) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology 280, E827E847.
Frühbeck, G, Gómez-Ambrosi, J & Salvador, J (2001b) Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB Journal 15, 333340.
Frühbeck, G, Rotellar, F, Hernández-Lizoain, JL, Gil, MJ, Gómez-Ambrosi, J, Salvador, J & Cienfuegos, JA (2004c) Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obesity Surgery 14, 12081215.
Frühbeck, G & Salvador, J (2004) Role of adipocytokines in metabolism and disease. Nutrition Research 24, 803826.
Fry, J & Finley, W (2005) The prevalence and costs of obesity in the EU. Proceedings of the Nutrition Society 64, 359362.
Fukuhara, A, Matsuda, M, Nishizawa, M, Segawa, K, Tanaka, M, Kishimoto, Ket al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426430.
Galuska, DA, Will, JC, Serdula, MK & Ford, ES (1999) Are health care professionals advising obese patiens to lose weight? Journal of the American Medical Association 282, 15761578.
Ghigo, E, Broglio, F, Arvat, E, Maccario, M, Papotti, M & Muccioli, G (2005) Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clinical Endocrinology 62, 117.
Gnanapavan, S, Kola, B, Bustin, SA, Morris, DG, McGee, P, Fairclough, P, Bhattacharya, S, Carpenter, R, Grossman, AB & Korbonits, M (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 87, 29882991.
Gómez-Ambrosi, J, Becerril, S, Oroz, P, Zabalza, S, Rodríguez, A, Muruzábal, FJ, Archanco, M, Gil, MJ, Burrell, MA & Frühbeck, G (2004a) Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations. FEBS Letters 577, 351356.
Gómez-Ambrosi, J, Catalán, V, Diez-Caballero, A, Martínez-Cruz, A, Gil, MJ, García-Foncillas, J, Cienfuegos, JA, Salvador, J, Mato, JM & Frühbeck, G (2004b) Gene expression profile of omental adipose tissue in human obesity. FASEB Journal 18, 215218.
Gómez-Ambrosi, J & Frühbeck, G (2001) Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Annals of Internal Medicine 135, 306307.
Gómez-Ambrosi, J & Frühbeck, G (2005a) Evidence for the involvement of resistin in inflammation and cardiovascular disease. Current Diabetes Reviews 1, 227234.
Gómez-Ambrosi, J & Frühbeck, G (2005b) Resistin: a promising therapeutic target for the management of type 2 diabetes mellitus? Drug Design Reviews – Online 2, 112.
Gómez-Ambrosi, J, Salvador, J, Páramo, JA, Orbe, J, de Irala, J, Diez-Caballero, A, Gil, MJ, Cienfuegos, JA & Frühbeck, G (2002) Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clinical Biochemistry 35, 315320.
Gómez-Ambrosi, J, Salvador, J, Rotellar, F, Silva, C, Catalán, V, Rodríguez, A, Gil, MJ & Frühbeck, G (2006a) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obesity Surgery 15, 262269.
Gómez-Ambrosi, J, Salvador, J, Silva, C, Pastor, C, Rotellar, F, Gil, MJ, Cienfuegos, JA & Frühbeck, G (2006b) Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Thrombosis and Haemostasis 95, 991996.
Gómez-Ambrosi, J, Salvador, J, Silva, C, Rotellar, F, Gil, MJ, Cienfuegos, JA & Frühbeck, G (2005) Leptin therapy does not affect inflammatory markers. Journal of Clinical Endocrinology and Metabolism 90, 3802.
Greenberg, AS, Taylor, SI & Londos, C (1987) Presence of a functional inhibitory GTP-binding regulatory component, Gi, linked to adenylate cyclase in adipocytes of ob/ob mice. Journal of Biological Chemistry 262, 45644568.
Gregg, EW, Cheng, YJ, Cadwell, BL, Imperatore, G, Williams, DE, Flegal, KM, Narayan, KMV & Williamson, DF (2005). Secular trends in cardiovascular risk factors according to body mass index in US adults. Journal of the American Medical Association 293, 18681874.
Grunweller, A & Hartmann, RK (2005) RNA interference as a gene-specific approach for molecular medicine. Current Medical Chemistry 12, 31433161.
Hansen, EN, Torquati, A & Abumrad, NN (2006) Results of bariatric surgery. Annual Reviews of Nutrition 26, 481511.
Hansson, GK (2005) Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 352, 16851695.
Hanush-Enserer, U, Brabant, G & Roden, M (2003). Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. New England Journal of Medicine 348, 21592160.
Hara-Chikuma, M, Sohara, E, Rai, T, Ikawa, M, Okabe, M, Sasaki, S, Uchida, S & Verkman, AS (2005) Progressive adipocyte hypertrophy in aquaporin-7-deficient mice. Journal of Biological Chemistry 280, 1549315496.
Hara-Chikuma, M & Verkman, AS (2006) Physiological roles of glycerol-transporting aquaporins: the aquaglyceroporins. Cellular and Molecular Life Sciences 63, 13861392.
Härle, P & Straub, RH (2006) Leptin is a link between adipose tissue and inflammation. Annals of the New York Academy of Sciences 1069, 454462.
Hauner, H (2005) Secretory factors from human adipose tissue and their functional role. Proceedings of the Nutrition Society 64, 163169.
Hetherington, AW & Ranson, SW (1940) Hypothalamic lesions and adiposity in the rat. The Anatomical Record 78, 149172.
Hibuse, T, Maeda, N, Funahashi, T, Yamamoto, K, Nagasawa, A, Mizunoya, Wet al. (2005) Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proceedings of the National Academy of Sciences USA 102, 1099310998.
Holcomb, IN, Kabakoff, RC, Chan, B, Baker, TW, Gurney, A, Henzel, Wet al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO Journal 19, 40464055.
Honnor, RC, Dhillon, GS & Londos, C (1985a) cAMPdependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. Journal of Biological Chemistry 260, 1512215129.
Honnor, RC, Dhillon, GS & Londos, C (1985b) cAMPdependent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. Journal of Biological Chemistry 260, 1513015138.
Hörig, H, Marincola, E & Marincola, FM (2005) Obstacles and opportunities in translational research. Nature Medicine 11, 705708.
Horvath, TL (2005) The hardship of obesity: a soft-wired hypothalamus. Nature Neuroscience 8, 561565.
Inui, A, Asakawa, A, Bowers, CY, Mantovani, G, Laviano, A, Meguid, MM & Fujimiya, M (2004) Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB Journal 18, 439456.
Ishibashi, K, Yamauchi, K, Kageyama, Y, Saito-Ohara, F, Ikeuchi, T, Marumo, F & Sasaki, S (1998) Molecular characterization of human Aquaporin-7 gene and its chromosomal mapping. Biochimica et Biophysica Acta 1399, 6266.
Ishikawa, Y, Otsu, K & Oshikawa, J (2005) Caveolin; different roles for insulin signal? Cellular Signalling 17, 11751182.
Jebb, SA, Siervo, M, Frühbeck, G, Murgatroyd, PR, Goldberg, G & Prentice, AM (2006) Variability of appetite control mechanisms in response to 9 weeks of progressive overfeeding in humans. International Journal of Obesity 30, 11601162.
Kadowaki, T & Yamauchi, T (2005) Adiponectin and adiponectin receptors. Endocrine Reviews 26, 439451.
Kawanami, D, Maemura, K, Takeda, N, Harada, T, Nojiri, T, Imai, Y, Manabe, I, Utsunomiya, K & Nagai, R (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochemical and Biophysical Research Communications 314, 415419.
Kawczynska-Drozdz, A, Olszanecki, R, Jawien, J, Brzozowski, T, Pawlik, WW, Korbut, R & Guzik, TJ (2006) Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. American Journal of Hypertension 19, 764767.
Kimura, K, Tsuda, K, Baba, A, Kawabe, T, Boh-oka, S, Ibata, M, Moriwaki, C, Hano, T & Nishio, I (2000) Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochemical and Biophysical Research Communications 273, 745749.
King, LS, Kozono, D & Agre, P (2004) From structure to disease: the evolving tale of aquaporin biology. Nature Reviews in Molecular Cell Biology 5, 687698.
Kishida, K, Shimomura, I, Kondo, H, Kuriyama, H, Makino, Y, Nishizawa, Het al. (2001) Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel. Journal of Biological Chemistry 276, 3625136260.
Klein, J, Perwitz, N, Kraus, D & Fasshauer, M (2006) Adipose tissue as source and target for novel therapies. Trends in Endocrinology and Metabolism 17, 2632.
Koerner, A, Kratzsch, J & Kiess, W (2005) Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Practice and Research in Clinical Endocrinology and Metabolism 19, 525546.
Kojima, M, Hosoda, H, Date, Y, Nakazato, M, Matsuo, H & Kangawa, K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656660.
Kondo, H, Shimomura, I, Kishida, K, Kuriyama, H, Makino, Y, Nishizawa, Het al. (2002) Human aquaporin adipose (AQPap) gene. Genomic structure, promoter analysis and functional mutation. European Journal of Biochemistry 269, 18141826.
Kopelman, PG (2000) Obesity as a medical problem. Nature 404, 635643.
Kralisch, S, Klein, J, Lossner, U, Bluher, M, Paschke, R, Stumvoll, M & Fasshauer, M (2005) Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. American Journal of Physiology 289, E586E590.
Krebs, JD, Evans, S, Cooney, L, Mishra, GD, Frühbeck, G, Finer, N & Jebb, SA (2002) Changes in risk factors for cardiovascular disease with body fat loss in obese women. Diabetes Obesity and Metabolism 4, 379387.
Kuriyama, H, Kawamoto, S, Ishida, N, Ohno, I, Mita, S, Matsuzawa, Y, Nishizawa, H, Matsubara, K & Okubo, K (1997) Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability. Biochemical and Biophysical Research Communication 241, 5358.
Kuriyama, H, Shimomura, I, Kishida, K, Kondo, H, Furuyama, N, Nishizawa, Het al. (2002) Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 51, 29152921.
LaNoue, KF & Martin, LF (1994) Abnormal A1 adenosine receptor function in genetic obesity. FASEB Journal 8, 7280.
Lau, DC, Dhillon, B, Yan, H, Szmitko, PE & Verma, S (2005) Adipokines: molecular links between obesity and atherosclerosis. American Journal of Physiology 288, H20312041.
Le Lay, S & Kurzchalia, TV (2005) Getting rid of caveolins: phenotypes of caveolin-deficient animals Biochemica et Biophysica Acta 1746, 322333.
Lehrke, M, Reilly, MP, Millington, SC, Iqbal, N, Rader, DJ & Lazar, MA (2004) An inflammatory cascade leading to hyperresistinemia in humans. PloS Medicine 1, 161168.
Lembo, G, Vecchione, C, Fratta, L, Marino, G, Trimarco, V, d'Amati, G & Trimarco, B (2000) Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 49, 293297.
MacDougald, OA & Burant, CF (2005) Obesity and metabolic perturbations after loss of aquaporin 7, the adipose tissue transporter. Proceedings of the National Academy of Sciences USA 102, 1075910760.
Maeda, N, Funahashi, T, Nagasawa, A, Kishida, K, Kuriyama, H, Nakamura, T, Kihara, S, Shimomura, I & Matsuzawa, Y (2004) Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue. Proceedings of the National Academy of Sciences USA 101, 1780117806.
Martin, LF, Klim, CM, Vannucci, SJ, Dixon, LB, Landis, JR & LaNoue, KF (1990) Alterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humans. Surgery 108, 228235.
Matsuzawa, Y (2005) White adipose tissue and cardiovascular disease. Best Practice and Research in Clinical Endocrinology and Metabolism 19, 637647.
Matsuzawa, Y (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nature Clinical Practice Cardiovascular Medicine 3, 3542.
Middleton, FA, Ramos, EJ, Xu, Y, Diab, H, Zhao, X, Das, UN & Meguid, M (2004) Application of genomic technologies: DNA microarrays and metabolic profiling of obesity in the hypothalamus and in subcutaneous fat. Nutrition 20, 1425.
Miyazawa-Hoshimoto, S, Takahashi, K, Bujo, H, Hashimoto, N & Saito, Y (2003) Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46, 14831488.
Mobasheri, A, Airley, R, Foster, CS, Schulze-Tanzil, G & Shakibaei, M (2004) Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery. Histology and Histopathology 19, 325355.
Mokdad, AH, Ford, ES, Bowman, BA, Dietz, WH, Vinicor, F, Bales, VS & Marks, JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 289, 7679.
Montecucco, F, Bianchi, G, Gnerre, P, Bertolotto, M, Dallegri, F & Ottonello, L (2006) Induction of neutrophil chemotaxis by leptin: crucial role for p38 and Src kinases. Annals of the New York Academy of Sciences 1069, 463471.
Morinigo, R, Casamitjana, R, Moize, V, Lacy, AM, Delgado, S, Gomis, R & Vidal, J (2004) Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obesity Research 12, 11081116.
Müller, M & Kersten, S (2003) Nutrigenomics: goals and strategies. Nature Reviews Genetics 4, 315322.
Nadler, ST & Attie, AD (2001) Please pass the chips: genomic insights into obesity and diabetes. Journal of Nutrition 131, 20782081.
National Audit Office (2001) Tackling Obesity in England. Report by the Comptroller and Auditor General HC 220 Session 2000–2001: 15 February 2001.
O'Brien, PE, Dixon, JB, Laurie, C, Skinner, S, Proietto, J, McNeil, J, Strauss, B, Marks, S, Schachter, L, Chapman, L & Anderson, M (2006) Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Annals of Internal Medicine 144, 625633.
Ogden, CL, Carroll, MD, Curtin, LR, McDowell, MA, Tabak, CJ & Flegal, KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. Journal of the American Medical Association 295, 15491555.
Olshansky, SJ, Passaro, DJ, Hershow, RC, Layden, J, Carnes, BA, Brody, J, Hayflick, L, Butler, RN, Allison, DB & Ludwig, DS (2005) A potential decline in life expectancy in the United States in the 21st century. New England Journal of Medicine 352, 11381145.
Oommen, AM, Griffin, JB, Sarath, G & Zempleni, J (2005) Roles for nutrients in epigenetic events. Journal of Nutritional Biochemistry 16, 7477.
Oshikawa, J, Otsu, K, Toya, Y, Tsunematsu, T, Hankins, R, Kawabe, J, Minamisawa, S, Umemura, S, Hagiwara, Y & Ishikawa, Y (2004) Insulin resistance in skeletal muscles of caveolin-3-null mice. Proceedings of the National Academy of Sciences USA 101, 1267012675.
Ouchi, N, Kihara, S, Arita, Y, Okamoto, Y, Maeda, N, Kuriyama, Het al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102, 12961301.
Ouchi, N, Kihara, S, Funahashi, T, Nakamura, T, Nishida, M, Kumada, Met al. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671674.
Papotti, M, Ghe, C, Cassoni, P, Catapano, F, Deghenghi, R, Ghigo, E & Muccioli, G (2000) Growth hormone secretagogue binding sites in peripheral human tissues. Journal of Clinical Endocrinology and Metabolism 85, 38033807.
Parton, RG, Hanzal-Bayer, M & Hancock, JF (2006) Biogenesis of caveolae: a structural model for caveolin-induced domain formation. Journal of Cell Science 119, 787796.
Parton, RG, Joggerst, B & Simons, K (1994) Regulated internalization of caveolae. Journal of Cell Biology 127, 11991215.
Peelman, F, Couturier, C, Dam, J, Zabeau, L, Tavernier, J & Jockers, R (2006) Techniques: new pharmacological perspectives for the leptin receptor. Trends in Pharmacological Sciences 27, 218225.
Permana, PA, Menge, C & Reaven, PD (2006) Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochemical and Biophysical Research Communication 341, 507514.
Pischon, T, Girman, CJ, Hotamisligil, GS, Rifai, N, Hu, FB & Rimm, EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association 291, 17301737.
Rankinen, T, Zuberi, A, Chagnon, YC, Weisnagel, Argyropoulos G, Walts, B, Pérusse, L & Bouchard, C (2006) The human obesity gene map: the 2005 update. Obesity 14, 529544.
Razani, B, Combs, TP, Wang, XB, Frank, PG, Park, DS, Russell, RG, Li, M, Tang, B, Jelicks, LA, Scherer, PE & Lisanti, MP (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Journal of Biological Chemistry 277, 86358647.
Rice, AM, Fain, JN & Rivkees, SA (2000) A1 adenosine receptor activation increases adipocyte leptin secretion. Endocrinology 141, 14421445.
Rodríguez, A, Frühbeck, G, Gómez-Ambrosi, J, Catalán, V, Sáinz, N, Díez, J, Zalba, G & Fortuño, A (2006) The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. Journal of Hypertension (In the Press).
Rothberg, KG, Heuser, JE, Donzell, WC, Ying, Y, Glenney, JR & Anderson, RGW (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68, 673682.
Ruden, DM, De Luca, M, Garfinkel, MD, Bynum, KL & Lu, X (2005) Drosophila nutrigenomics can provide clues to human gene-nutrient interactions. Annual Review of Nutrition 25, 499522.
Rybin, VO, Grabham, PW, Elouardighi, H & Steinberg, SF (2003) Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. American Journal of Physiology 285, H325H332.
Sakata, I, Nakamura, K, Yamazaki, M, Matsubara, M, Hayashi, Y, Kangawa, K & Sakai, T (2002) Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 23, 531536.
Scherer, PE, Lewis, RY, Volonte, D, Engelman, JA, Galbiati, F, Couet, J, Kohtz, DS, van Donselaar, E, Peters, P & Lisanti, MP (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 colocalize and form a stable hetero-oligomieric complex in vivo. Journal of Cell Biology 272, 2933729346.
Sethi, JK & Vidal-Puig, A (2005) Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine 11, 344347.
Shankar, P, Manjunath, N & Lieberman, J (2005) The prospect of silencing disease using RNA interference. Journal of the American Medical Association 293, 13671373.
Shimizu, Y, Nagaya, N, Teranishi, Y, Imazu, M, Yamamoto, H, Shokawa, T, Kangawa, K, Kohno, N & Yoshizumi, M (2003) Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochemical and Biophysical Research Communications 310, 830835.
Sjöholm, K & Nyström, T (2005) Endothelial inflammation in insulin resistance. Lancet 365, 610612.
Sjöholm, K, Palming, J, Olofsson, LE, Gummesson, A, Svensson, PA, Lystig, TC, Jennische, E, Brandberg, J, Torgerson, JS, Carlsson, B & Carlsson, LM (2005) A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid. Journal of Clinical Endocrinology and Metabolism 90, 22332239.
Skilton, MR, Nakhla, S, Sieveking, DP, Caterson, ID & Celermajer, DS (2005) Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clinical and Experimental Pharmacology and Physiology 32, 839844.
Song, KS, Scherer, PE, Tang, ZL, Okamoto, T, Li, S, Chu, C, Chafel, M, Chu, C, Kohtz, DS & Lisanti, MP (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. Journal of Biological Chemistry 271, 1516015165.
Stan, RV (2005) Structure of caveolae. Biochemica et Biophysica Acta 1746, 334348.
Steinbrook, R (2004) Surgery for severe obesity. New England Journal of Medicine 350, 10751079.
Steppan, CM, Bailey, ST, Bhat, S, Brown, EJ, Banerjee, RR, Wright, CM, Patel, HR, Ahima, RS & Lazar, MA (2001) Nature 409, 307312.
Steppan, CM & Lazar, MA (2004) The current biology of resistin. Journal of Internal Medicine 255, 439447.
Tang, ZL, Scherer, PE, Okamoto, T, Song, K, Chu, C, Kohtz, DS, Nishimoto, I, Lodish, HF & Lisanti, MP (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. Journal of Biological Chemistry 271, 22552261.
Tomasetto, C, Karam, SM, Ribieras, Set al. (2000) Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119, 395405.
Trayhurn, P (2005a) Obesity – what role now for nutritional science? British Journal of Nutrition 93, 12.
Trayhurn, P (2005b) The biology of obesity. Proceedings of the Nutrition Society 64, 3138.
Trayhurn, P & Beattie, JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society 60, 329339.
Trayhurn, P & Wood, IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 92, 347355.
Urieli-Shoval, S, Linke, RP & Matzner, Y (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Current Opinion in Hematology 7, 6469.
Vaidya, V (2006) Psychosocial aspects of obesity. Advances in Psychosomatic Medicine 27, 7385.
Vannucci, SJ, Klim, CM, Martin, LF & LaNoue, KF (1989) A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats. American Journal of Physiology 257, E871E878.
Vecchione, C, Maffei, A, Colella, S, Aretini, A, Poulet, R, Frati, G, Gentile, MT, Fratta, L, Trimarco, V, Trimarco, B & Lembo, G (2002) Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51, 168173.
Verkman, AS (2005) More than just water channels: unexpected cellular roles of aquaporins. Journal of Cellular Science 118, 32253232.
Verma, S, Li, SH, Wang, CH, Fedak, PW, Li, RK, Weisel, RD & Mickle, DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108, 736740.
Viguerie, N, Poitou, C, Cancello, R, Stich, V, Clement, K & Langin, D (2005) Transcriptomics applied to obesity and caloric restriction. Biochimie 87, 117123.
Wang, M-Y, Lee, Y & Unger, RH (1998) Novel form of lipolysis induced by leptin. Journal of Biological Chemistry 274, 1754117544.
Wellen, KE & Hotamisligil, GS (2003) Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation 112, 17851788.
Wiley, KE & Davenport, AP (2002) Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. British Journal of Pharmacology 136, 11461152.
Winters, B, Mo, Z, Brooks-Asplund, E, Kim, S, Shoukas, A, Li, D, Nyhan, D & Berkowitz, DE (2000) Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep ob) mice. Journal of Applied Physiology 89, 23822390.
Wintour, EM & Henry, BA (2006) Glycerol transport: an additional target for obesity therapy? Trends in Endocrinology and Metabolism 17, 7778.
Xydakis, AM, Case, CC, Jones, PH, Hoogeveen, RC, Liu, M-Y, O'Brian, Smith E, Nelson, KW & Ballantyne, CM (2004) Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. Journal of Clinical Endocrinology and Metabolism 89, 26972703.
Yamamoto, M, Toya, Y, Schwencke, C, Lisanti, MP, Myers, MG Jr & Ishikawa, Y (1998) Caveolin is an activator of insulin receptor signaling. Journal of Biological Chemistry 273, 26962–26968.
Yamauchi, T, Kamon, J, Ito, Y, Tsuchida, A, Yokomizo, T, Kita, Set al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762769.
Yu, YH & Ginsberg, HN (2005) Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circulation Research 96, 10421052.
Zerhouni, EA (2005) Translational and clinical science – time for a new vision. New England Journal of Medicine 353, 16211623.



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed